![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0147.png)
145
SCIENTIFIC PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
MONDAY 2 MAY 2016
16:55 > Heterogeneous FDG-guided dose escalation of locally advanced NSCLC,
the NARLAL2 phase III trial
D.S. Moeller (Denmark), L. Hoffmann, C.M. Lutz, T.B. Nielsen, C. Brink,
A.L. Appelt, M.D. Lund, M.S. Nielsen, W. Ottosson, A.A. Khalil,
M.M. Knap, O. Hansen, T. Schytte
OC-0544
17:05 > Results of a national audit of IMRT and VMAT patient QA
E. Seravalli (The Netherlands), A.C. Houweling, M.P.R. Van Gellekom,
J. Kaas, M. Kuik, E.A. Loeff, T.A. Raaben, J.A. De Pooter, J.H.W. De Vries,
J.B. Van de Kamer
OC-0545
17:15 > The development of proton-beam grid therapy (PBGT)
T. Henry (Sweden), A. Valdman, A. Siegbahn
OC-0546
17:25 > Towards Portal Dosimetry for the MR-linac: back-projection algorithm
in the presence of MRI scanner
I. Torres Xirau (The Netherlands), R. Rozendaal, I. Olaciregui-Ruiz,
P. Gonzalez, U. Van der Heide, J.J. Sonke, A. Mans
OC-0547
17:35 > Hyperthermia treatment planning in the pelvis using thermophysical
fluid modelling of the bladder
G. Schooneveldt (The Netherlands), H.P. Kok, E.D. Geijsen, A. Bakker,
E. Balidemaj, J.J.M.C.H. De la Rosette, M.C.C.M. Hulshof, T.M. De Reijke,
J. Crezee
OC-0548
Proffered Papers
PHYSICS 14: TREATMENT PLANNING: APPLICATIONS II
16:45 - 17:45 | ROOM 500
Chair: M. Tenhunen (Finland)
Chair: E. Moretti (Italy)
16:45 > The effects of a magnetic field and real-time tumor tracking on lung
stereotactic body radiotherapy
M.J. Menten (UK), M.F. Fast, S. Nill, C.P. Kamerling,
F. McDonald, U. Oelfke
OC-0549
16:55 > Investigation of magnetic field effects for the treatment planning of lung
cancer
O. Schrenk (Germany), C.K. Spindeldreier, A. Pfaffenberger
OC-0550
17:05 > Advantage of IMPT over IMRT in treatment of gynaecological cancer
with para-aortic nodal involvement
M. Van de Sande (The Netherlands), C.L. Creutzberg, S. Van de Water,
A.W. Sharfo, M.S. Hoogeman
OC-0551